| Axis | Max value (= vertex) |
|---|---|
| Market Cap | $2B |
| Assets/Liabilities | 2 |
| E/P Ratio | 1/15 |
| Book Value/Price | 1/1.5 |
| Dividend Yield | 5% |
| 10Y Earnings Growth | 0.5 |
Akari Therapeutics, Plc (AKTX) last closed at $8.34 on October 26, 2026. AKTX did not report a dividend for the last fiscal year.